Amgen's Imdelltra scores again in small cell lung cancer
Amgen's Imdelltra scores again in small cell lung cancer pharmaphorum
Онкология
Рак лёгких
277 материалов по теме, собраны автоматически из проверенных источников
Онкология
Gut, Airway and Tumor Microbes Emerge as Promising Predictors of Immunotherapy Response in Lung Cancer | Newswise
Gut, Airway and Tumor Microbes Emerge as Promising Predictors of Immunotherapy Response in Lung Cancer | Newswise Newswise
Онкология
American Lung Association Puts a Spotlight on Clinical Trials and How They Can Offer Hope to People Living With Lung Cancer
American Lung Association Puts a Spotlight on Clinical Trials and How They Can Offer Hope to People Living With Lung Cancer PR Newswire
Онкология
American Lung Association Puts a Spotlight on Clinical Trials and How They Can Offer Hope to People Living With Lung Cancer
American Lung Association Puts a Spotlight on Clinical Trials and How They Can Offer Hope to People Living With Lung Cancer Yahoo Finance Singapore
Онкология
Amgen and AstraZeneca report survival improvement in lung cancer trial
Amgen and AstraZeneca report survival improvement in lung cancer trial Yahoo Finance UK
🎗️
Онкология
Amgen and AstraZeneca report positive lung cancer trial results
Amgen and AstraZeneca report positive lung cancer trial results Investing.com
🎗️
Онкология
Amgen claims win for Imdelltra in maintenance lung cancer setting
Amgen claims win for Imdelltra in maintenance lung cancer setting FirstWord PHARMA
Онкология
Lung Cancer Treatment May Become More Adaptive With a Simple Blood Test
Lung Cancer Treatment May Become More Adaptive With a Simple Blood Test SurvivorNet
🎗️
Онкология
A lung cancer patient was tumor-free for 10 years after selenite. What should oncologists make of it?
A lung cancer patient was tumor-free for 10 years after selenite. What should oncologists make of it? MDLinx
🎗️
Онкология
Amgen’s DLL3-targeted Imdelltra scores overall survival win in first-line small cell lung cancer
Amgen’s DLL3-targeted Imdelltra scores overall survival win in first-line small cell lung cancer Fierce Pharma
🎗️
Онкология
AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review
AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review WSJ
Онкология
IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER PR Newswire
🎗️
Онкология
Imfinzi plus Imdelltra demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small cell lung cancer
Imfinzi plus Imdelltra demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stage small cell lung cancer AstraZeneca
Онкология
Израиль разработал чип для анализа крови, позволяющий выявлять рак легких с точностью до 93%.
Израиль разработал чип для анализа крови, позволяющий выявлять рак легких с точностью до 93%. vietnam.vn
🎗️
Онкология
Rasonque Lung Cancer Data: What the 42% Really Means
Rasonque Lung Cancer Data: What the 42% Really Means Technology Org